Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 18, 2016 ) LVADs supplement the pumping of blood by weak hearts. Surgeons implant this mechanical device as a treatment option for severe heart conditions such as acute or chronic deterioration of cardiac functions and heart failure. Surgeons also use the device for BTT, BTR, BTD, and destination therapies.
Publisher's analysts forecast the global LVAD market to grow at a CAGR of 13.19% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-lvad-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global LVAD market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of LVADs.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Left Ventricular Assist Device (LVAD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Abiomed - Berlin Heart - HeartWare International - Jarvik Heart - St. Jude Medical
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001291817/sample
Other prominent vendors - Cardiac Assist - Evaheart - ReliantHeart - Sun Medical Technology Research - Sunshine Heart
Market driver - Shortage of heart donors - For a full, detailed list, view our report
Market challenge - Availability of alternative treatments - For a full, detailed list, view our report
Market trend - Increase in M&A - For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001291817/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|